Results 161 to 170 of about 16,411 (192)

Evaluation of postoperative bleeding and pain following tooth extraction in patients using direct oral anticoagulants: a prospective case-control study with blinded evaluation. [PDF]

BMC Oral Health
Kaya İ.
europepmc   +1 more source

Micellar Liquid Chromatography Determination of Edoxaban in Oral Solid Dosage Forms: Theoretical Aspects and Validation. [PDF]

ChemMedChem
Peris-Vicente J, Bose D, Pawar RP, Durgbanshi A, Carda-Broch S.   +4 more
europepmc   +1 more source

Effects of DOACs on Mouse Melanoma Metastasis and the Inhibitory Mechanism of Edoxaban, a Factor Xa-Specific DOAC. [PDF]

TH Open
Hiramoto K, Watanabe T, Imai M, Suzuki K.   +3 more
europepmc   +1 more source

Effects of anticoagulation in patients with device-detected atrial fibrillation and multiple stroke risk factors: a win ratio analysis of the NOAH-AFNET 6 trial. [PDF]

Eur Heart J Qual Care Clin Outcomes
Becher N, Köllner G, Bertaglia E, Blomstrom-Lundqvist C, Brandes A, Beuger V, Calvert M, Camm AJ, Cabanelas N, Chlouverakis G, Dan GA, Dichtl W, Diener HC, Fierenz A, Goette A, de Groot JR, Kennes LN, Lip GYH, Lubinski A, Marijon E, Merkely B, Mont L, Rajappan K, Rohrer U, Sarkozy A, Schotten U, Sehner S, Simantirakis E, Toennis T, Vardas P, Velchev V, Wichterle D, Zapf A, Kirchhof P.   +33 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Edoxaban

Reactions Weekly
  +12 more sources

Edoxaban Tosylate

American Journal Cardiovascular Drugs, 2011
Daiichi Sankyo is developing edoxaban tosylate (DU 176b; DU-176; DU-176b; DU176b) as an orally active direct factor Xa inhibitor for the prevention of stroke and the prevention and treatment of venous thromboembolism. Two dosing regimens of edoxaban tosylate are being compared with warfarin over 24 months in the ENGAGE AF TIMI 48 trial (NCT00781391) in
openaire   +2 more sources

Edoxaban

Reactions Weekly, 2023
  +7 more sources